Cargando…
hMENA splicing program impacts the clinical outcome of early stage lung cancer patients. How and why?
Autores principales: | Visca, Paolo, Spada, Sheila, Di Modugno, Francesca, Bria, Emilio, Sperduti, Isabella, Antoniani, Barbara, Alessandrini, Gabriele, Palermo, Belinda, Ludovini, Vienna, Crinò, Lucio, Facciolo, Francesco, Milella, Michele, Mottolese, Marcella, Nisticò, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108875/ http://dx.doi.org/10.1186/1479-5876-12-S1-P12 |
Ejemplares similares
-
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
por: Bria, Emilio, et al.
Publicado: (2014) -
hMENA isoforms impact NSCLC patient outcome through fibronectin/β1 integrin axis
por: Di Modugno, Francesca, et al.
Publicado: (2018) -
The actin modulator hMENA regulates GAS6‐AXL axis and pro‐tumor cancer/stromal cell cooperation
por: Melchionna, Roberta, et al.
Publicado: (2020) -
hMENA(11a), a hMENA isoform sending survival signals
por: Trono, Paola, et al.
Publicado: (2015) -
The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
por: Di Modugno, Francesca, et al.
Publicado: (2010)